Steven G Terra

Title: The Innovations of Steven G Terra

Introduction

Steven G Terra is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular events and metabolic disorders. With a total of 4 patents to his name, Terra's work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors. This invention relates to the use of certain SGLT-2 inhibitors, such as ertugliflozin, for treating and preventing heart failure, myocardial infarction, cardiovascular disease, or cardiovascular death in animals, regardless of their diabetes status. Another significant patent addresses the use of SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease. This invention also includes methods for preventing neuronal damage following ischemic stroke and traumatic brain injury by administering ertugliflozin.

Career Highlights

Throughout his career, Steven G Terra has worked with prominent companies such as Merck Sharp & Dohme Corp. and Pfizer Corporation. His experience in these leading pharmaceutical companies has contributed to his expertise in developing innovative treatments.

Collaborations

Some of his notable coworkers include James Michael Rusnak and Ramachandra G Naik. Their collaboration has likely fostered an environment of innovation and advancement in their respective fields.

Conclusion

Steven G Terra's contributions to medical innovation through his patents and collaborations highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the treatment of cardiovascular and metabolic disorders.